Intest Res.  2014 Oct;12(4):263-265. 10.5217/ir.2014.12.4.263.

Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?

• Ye BD

• KMID: 2174400
• DOI: http://doi.org/10.5217/ir.2014.12.4.263

Abstract

No abstract available.

MeSH Terms

Crohn Disease*
Necrosis*
Prognosis*

Reference

1. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV Jr. Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol. 2012; 107:1693–1701. PMID: 22945286.

2. Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010; 59:1200–1206. PMID: 20650924.

3. Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol. 2012; 107:579–588. PMID: 22233693.

4. Cosnes J, Bourrier A, Laharie D, et al. Early administration of azathioprine vs conventional management of Crohn's disease: a randomized controlled trial. Gastroenterology. 2013; 145:758–765. PMID: 23644079.

5. Panes J, Lopez-Sanroman A, Bermejo F, et al. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Gastroenterology. 2013; 145:766–774. PMID: 23770132.

6. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362:1383–1395. PMID: 20393175.

7. Sandborn WJ, Hanauer S, Van Assche G, et al. Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases. J Crohns Colitis. 2014; 8:927–935. PMID: 24713173.

8. Ghazi LJ, Patil SA, Rustgi A, Flasar MH, Razeghi S, Cross RK. Step up versus early biologic therapy for Crohn's disease in clinical practice. Inflamm Bowel Dis. 2013; 19:1397–1403. PMID: 23598813.

9. Kim NH, Jung YS, Moon CM, et al. Long-term clinical outcomes of Korean patient with Crohn's disease following early use of infliximab. Intest Res. 2014; 12:281–286.

10. Domènech E, Zabana Y, Garcia-Planella E, et al. Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability. Aliment Pharmacol Ther. 2010; 31:233–239. PMID: 19832727.